|
CID16020046
- 品牌：MedKoo
- 产地：美国
- 货号：513693
- cas：834903-43-4
- 发布日期： 2022-07-20
- 更新日期： 2024-08-12
产品详请
| 产地 | 美国 |
| 品牌 | MedKoo |
| 货号 | 513693 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包装规格 | 25.0mg; 50.0mg; 100.0mg; 200.0mg; 500.0mg; 1.0g; 2.0g; |
| CAS编号 | 834903-43-4 |
| 纯度 | >98%% |
| 是否进口 | 是 |
中文名称:4-[4,6-二氢-4-(3-羟基苯基)-3-(4-甲基苯基)-6-氧代吡咯并[3,4-C]吡唑-5(1H)-基]苯甲酸
CAS No:834903-43-4
分子式:C25H19N3O4
沸点:748.1±60.0 °C(Predicted)
密度:1.425±0.06 g/cm3(Predicted)
用途:CID 16020046 is a selective GPR55 antagonist. It Inhibits LPI-induced Ca2+ signaling, ERK1/2 phosphorylation and GPR55-mediated transcription factor activation. It displays weak inhibition of acetylcholinesterase, μ-opioid receptor, KCNH2 and hERG. It decreases LPI-induced GPR55 internalization. CI..
安全说明:26
CAS No:834903-43-4
分子式:C25H19N3O4
沸点:748.1±60.0 °C(Predicted)
密度:1.425±0.06 g/cm3(Predicted)
用途:CID 16020046 is a selective GPR55 antagonist. It Inhibits LPI-induced Ca2+ signaling, ERK1/2 phosphorylation and GPR55-mediated transcription factor activation. It displays weak inhibition of acetylcholinesterase, μ-opioid receptor, KCNH2 and hERG. It decreases LPI-induced GPR55 internalization. CI..
安全说明:26
